摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-fluorophenyl)-5-(4-methylsulfonylphenyl)-3-(tetrahydro-4H-pyran-4-on-3-yloxy)pyrazole | 329076-69-9

中文名称
——
中文别名
——
英文名称
4-(4-fluorophenyl)-5-(4-methylsulfonylphenyl)-3-(tetrahydro-4H-pyran-4-on-3-yloxy)pyrazole
英文别名
3-[(4-(4-fluorophenyl)-5-(4-(methylsulphonyl)phenyl)-1H-pyrazol-3-yl)oxy]tetrahydro-4H-pyran-4-one;3-[[4-(4-fluorophenyl)-5-(4-methylsulfonylphenyl)-1H-pyrazol-3-yl]oxy]oxan-4-one
4-(4-fluorophenyl)-5-(4-methylsulfonylphenyl)-3-(tetrahydro-4H-pyran-4-on-3-yloxy)pyrazole化学式
CAS
329076-69-9
化学式
C21H19FN2O5S
mdl
——
分子量
430.457
InChiKey
SDMHQRGTGODLBJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    30
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    107
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(4-fluorophenyl)-5-(4-methylsulfonylphenyl)-3-(tetrahydro-4H-pyran-4-on-3-yloxy)pyrazole4-甲基苯磺酸吡啶溶剂黄146 作用下, 以 甲苯 为溶剂, 反应 18.0h, 生成 3-(4-fluorophenyl)-2-(4-methylsulfonylphenyl)-7,8-dihydro-5H-pyrazolo[5,1-b]pyrano[4,3-d][1,3]oxazole
    参考文献:
    名称:
    Synthesis of 4,5-Diaryl-1H-pyrazole-3-ol Derivatives as Potential COX-2 Inhibitors
    摘要:
    4,5-Diaryl-1H-pyrazole-3-ol was utilized as a versatile template to synthesize several classes of compounds such as pyrazolo-oxazines 7, pyrazolo-benzooxazines 9, pyrazolo-oxazoles 10, and its analogues 11a-c as potential COX-2 inhibitors. Compounds 11b,c were successfully synthesized with use of pyridinium p-toluenesulfonate mediated cyclization of the ketal intermediate. Diaryl-pyrazolo-benzooxazepine analogues were synthesized by using Cu-mediated cyclization of the O-alkylated arylbromide intermediate. Arylsulfonamides were synthesized efficiently on a large scale with 4-[4-(4-fluorophenyl)-5-hydroxy-2H-pyrazol-3-yl]benzenesulfonamide 31 template readily synthesized from commercially available 4-sulfamoyl benzoic acid 29. The structure of a representative compound from each class was confirmed by X-ray crystallography. Selected compounds tested for inhibitory activity against COX-1 and COX-2 enzymes showed good selectivity for COX-2 versus COX-1 enzyme.
    DOI:
    10.1021/jo049264k
  • 作为产物:
    参考文献:
    名称:
    Synthesis of 4,5-Diaryl-1H-pyrazole-3-ol Derivatives as Potential COX-2 Inhibitors
    摘要:
    4,5-Diaryl-1H-pyrazole-3-ol was utilized as a versatile template to synthesize several classes of compounds such as pyrazolo-oxazines 7, pyrazolo-benzooxazines 9, pyrazolo-oxazoles 10, and its analogues 11a-c as potential COX-2 inhibitors. Compounds 11b,c were successfully synthesized with use of pyridinium p-toluenesulfonate mediated cyclization of the ketal intermediate. Diaryl-pyrazolo-benzooxazepine analogues were synthesized by using Cu-mediated cyclization of the O-alkylated arylbromide intermediate. Arylsulfonamides were synthesized efficiently on a large scale with 4-[4-(4-fluorophenyl)-5-hydroxy-2H-pyrazol-3-yl]benzenesulfonamide 31 template readily synthesized from commercially available 4-sulfamoyl benzoic acid 29. The structure of a representative compound from each class was confirmed by X-ray crystallography. Selected compounds tested for inhibitory activity against COX-1 and COX-2 enzymes showed good selectivity for COX-2 versus COX-1 enzyme.
    DOI:
    10.1021/jo049264k
点击查看最新优质反应信息

文献信息

  • SULFONYLPHENYLPYRAZOLE COMPOUNDS USEFUL AS COX-2 INHIBITORS
    申请人:ABBOTT LABORATORIES
    公开号:EP1206474B1
    公开(公告)日:2004-05-26
  • US6472416B1
    申请人:——
    公开号:US6472416B1
    公开(公告)日:2002-10-29
  • [EN] SULFONYLPHENYLPYRAZOLE COMPOUNDS USEFUL AS COX-2 INHIBITORS<br/>[FR] COMPOSES SULFONYLPHENYLPYRAZOLES UTILES EN TANT QU'INHIBITEURS DE COX-2
    申请人:ABBOTT LAB
    公开号:WO2001016138A1
    公开(公告)日:2001-03-08
    The present invention encompasses novel sulfonylphenylpyrazole compounds useful in the treatment of cyclooxygenase-2 mediated diseases.
查看更多